Sm. Donovan et al., INVESTIGATION INTO THE POTENTIAL PHYSIOLOGICAL SOURCES OF RAT MILK IGF-I AND IGF-BINDING PROTEINS, Journal of Endocrinology, 145(3), 1995, pp. 569-578
We have previously reported the presence of IGF-I and IGF-binding prot
eins (IGFBP-2, -3 and -4) in rat milk. Herein, the potential sources o
f rat milk IGF-I and IGFBPs were investigated. Lactating dam (day 14 p
ostpartum) were separated from their pups and injected intraperitoneal
ly with 0.45 mu Ci I-125-IGF-I Or I-125-IGFBP-3. After 3 h, serum and
milk of rats receiving I-125-IGF-I contained 7642 +/- 3121 and 14 455
+/- 7837 c.p.m./ml respectively. Serum and milk of rats given I-125-IG
FBP-3 contained 7232 +/- 1366 and 10 371 +/- 4091 c.p.m./ml respective
ly. Sephacryl S-200 gel filtration chromatography demonstrated that th
e I-125-IGF-I in both serum and milk was primarily in the 150 kDa IGF-
binding complex, whereas the distribution of I-125-IGFBP-3 differed be
tween serum and milk. In serum, most of the I-125-IGFBP-3 was in the 1
50 kDa fraction, while most I-125-IGFBP-3 in milk was in the 40 kDa fr
action. Northern analysis of liver showed IGFBP-1 and -3 mRNA expressi
on, with variable expression of IGFBP-2 and -4 mRNA. In contrast, mamm
ary tissue expressed only IGFBP-2 and -4 mRNA, suggesting that these I
GFBPs in milk may arise from de novo synthesis within the mammary glan
d. The lack of detectable IGFBP-3 mRNA in mammary tissue and the trans
location I-125-IGFBP-3 from the serum suggest that milk IGFBP-3 arises
from the maternal circulation.